172152-53-3

Basic information

• Product Name: 5-(1H-Pyrrol-1-yl)-2-mercaptobenzimidazole
• Synonyms: 5-(1H-pyrrol-1-yl)-1H-benzo[d]iMidazole-2-thiol;1,3-dihydro-5-(1H-pyrrol-1-yl)-2H-Benzimidazole-2-thione;5-pyrrol-1-yl-1,3-dihydrobenzimidazole-2-thione;5-(1H-Pyrrol-1-yl)-2-mercaptobenzimidazole
• CAS NO: 172152-53-3
• Molecular Formula: C₁₁H₉N₃S
• Molecular Weight: 215
• EINECS: 1308068-626-2
• Mol File: 172152-53-3.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 381.7±44.0 °C(Predicted)
• Appearance: /
• Density: 1.40
• Storage Temp.: 2-8°C
• PKA: 9.61±0.30(Predicted)
• CAS DataBase Reference: 5-(1H-Pyrrol-1-yl)-2-mercaptobenzimidazole(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(1H-Pyrrol-1-yl)-2-mercaptobenzimidazole(172152-53-3)
• EPA Substance Registry System: 5-(1H-Pyrrol-1-yl)-2-mercaptobenzimidazole(172152-53-3)

Safety Data

• Hazardous Substances Data: 172152-53-3(Hazardous Substances Data)

Usage

General Description

5-(1H-Pyrrol-1-yl)-2-mercaptobenzimidazole is a complex organic compound that is often used in the field of chemistry. Its molecular formula is C11H9N3S and has a molar mass of 215.27 g/mol. As with many such compounds, it should be handled with care as it can pose certain hazards like irritating the respiratory system and eyes upon exposure. It is known to be soluble in benzene and ethanol. Despite its potential hazards, this compound is useful in many scientific and industrial applications. However, specific details about its uses and properties vary and require more detailed research to fully understand its potential applications and risks.

Upstream product

• 6325-91-3 5-nitro-2-mercaptobenzimidazole 
• 696-59-3 cis,trans-2,5-dimethoxytetrahydrofuran 
• 2818-66-8 5-amino-2-mercaptobenzimidazole 

Downstream Products

• 172152-35-1 2-(((4-methoxy-3-methylpyridin-2-yl)methyl)thio)-5-(1H-pyrrol-1-yl)-1H-benzo[d]imidazole 

Relevant articles and documents

Diversified synthesis of novel quinoline and dibenzo thiazepine derivatives using known active intermediates

The novel drug development to control resisting infections in conventional drug therapy is a need of today. Few antiulcer relative derivatives developed by approaching convergent synthesis. The derivatives synthesized successfully are dibenzo thiazepine-pyridine (SLN11-SLN15) and benzimidazole-hydroquinoline based derivatives (SLN16-SLN20). It involved the coupling through microwave, sonication and conventional techniques at final step. The efficient technology identified as sonication technique basically time and yield. The reported compounds were structural characterized by elemental analysis and spectral studies such as 1H, 13C NMR and MS.

PROCESS FOR PREPARING INTERMEDIATE COMPOUND FOR SYNTHESIZING AN ANTIULCERANT

The present invention relates a novel method of preparing an intermediate which is useful for synthesizing an antiulcerant. The present invention provides a method of preparing an intermediate of an antiulcerant which can obtain a high purity compound in high yield, with reduced production cost/time as compared to a conventional method.